Shire PLC (LON:SHP) Stock Rating Reaffirmed by Analysts at Deutsche Bank; The GBX 4500.00 Target Indicates 40.19% Potential; Robert Half International (RHI) Shorts Up By 11.78%

In an analyst report sent to investors and clients on 15 February, Shire PLC (LON:SHP) stock “Buy” was reaffirmed by Analysts at Deutsche Bank. They currently have a GBX 4500.00 price target on the stock. Deutsche Bank’s price target would indicate a potential upside of 40.19% from the company’s current price.

Robert Half International Incorporated (NYSE:RHI) had an increase of 11.78% in short interest. RHI’s SI was 2.95M shares in February as released by FINRA. Its up 11.78% from 2.64 million shares previously. With 969,200 avg volume, 3 days are for Robert Half International Incorporated (NYSE:RHI)’s short sellers to cover RHI’s short positions. The SI to Robert Half International Incorporated’s float is 2.39%. The stock increased 2.71% or $1.48 during the last trading session, reaching $56.12. About 1.24 million shares traded or 20.04% up from the average. Robert Half International Inc. (NYSE:RHI) has risen 17.82% since February 15, 2017 and is uptrending. It has outperformed by 1.12% the S&P500.

Among 26 analysts covering Shire PLC (LON:SHP), 21 have Buy rating, 0 Sell and 5 Hold. Therefore 81% are positive. Shire PLC has GBX 8000 highest and GBX 214 lowest target. GBX 5217.83’s average target is 65.36% above currents GBX 3155.5 stock price. Shire PLC had 411 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by JP Morgan on Monday, November 21 with “Overweight”. UBS maintained the shares of SHP in report on Wednesday, October 21 with “Buy” rating. The firm has “Buy” rating by Jefferies given on Friday, February 12. On Thursday, October 15 the stock rating was maintained by AlphaValue with “Buy”. Bryan Garnier & Cie maintained it with “Buy” rating and GBX 6800 target in Monday, January 9 report. Citigroup maintained the stock with “Buy” rating in Friday, January 5 report. The company was maintained on Friday, September 4 by BNP Paribas. The firm earned “Outperform” rating on Monday, March 13 by RBC Capital Markets. The firm has “Buy” rating by Shore Capital given on Tuesday, May 2. The rating was maintained by JP Morgan with “Overweight” on Wednesday, January 4.

The stock increased 0.64% or GBX 20 during the last trading session, reaching GBX 3155.5. About 342,733 shares traded. Shire plc (LON:SHP) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Shire plc, a biotechnology company, focused on serving people with rare diseases and other specialized conditions worldwide. The company has market cap of 28.49 billion GBP. The firm offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. It has a 17.89 P/E ratio. The Company’s marketed products include ADVATE and ADYNOVATE/ADYNOVI for hemophilia A; RIXUBIS to treat hemophilia B; VONVENDI for the treatment of von willebrand Disease; FEIBA to treat hemophilia A and B patients with inhibitors; CINRYZE and FIRAZYR for hereditary angioedema; ELAPRASE to treat hunter syndrome; REPLAGAL for Fabry disease; and VPRIV to treat type 1 Gaucher disease.

Robert Half International Inc. provides staffing and risk consulting services in North America, South America, Europe, Asia, and Australia. The company has market cap of $6.91 billion. The firm operates through three divisions: Temporary and Consultant Staffing, Permanent Placement Staffing, and Risk Consulting and Internal Audit Services. It has a 24.09 P/E ratio. It places temporary personnel for accounting, finance, and bookkeeping; temporary and full-time office and administrative personnel consisting of executive and administrative assistants, receptionists, and customer service representatives; full-time accounting, financial, tax, and accounting activities personnel; and information technology contract consultants and full-time employees in the areas of platform systems integration and end-user support, including specialists in Web development, networking, application development, systems integration, database design, security and business continuity, and desktop support.

Among 14 analysts covering Robert Half International (NYSE:RHI), 4 have Buy rating, 3 Sell and 7 Hold. Therefore 29% are positive. Robert Half International has $67.0 highest and $33 lowest target. $54.75’s average target is -2.44% below currents $56.12 stock price. Robert Half International had 40 analyst reports since July 28, 2015 according to SRatingsIntel. BMO Capital Markets maintained the shares of RHI in report on Friday, October 13 with “Hold” rating. BMO Capital Markets maintained Robert Half International Inc. (NYSE:RHI) on Wednesday, October 25 with “Market Perform” rating. The stock has “Outperform” rating by RBC Capital Markets on Thursday, October 22. Macquarie Research initiated Robert Half International Inc. (NYSE:RHI) rating on Friday, August 26. Macquarie Research has “Neutral” rating and $43 target. The firm earned “Market Perform” rating on Wednesday, July 27 by BMO Capital Markets. Robert W. Baird maintained Robert Half International Inc. (NYSE:RHI) rating on Wednesday, October 25. Robert W. Baird has “Outperform” rating and $55 target. The stock of Robert Half International Inc. (NYSE:RHI) earned “Underweight” rating by Barclays Capital on Friday, October 23. Barclays Capital maintained the stock with “Equal-Weight” rating in Wednesday, January 31 report. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, January 30. The stock has “Buy” rating by Jefferies on Friday, July 31.

Since February 2, 2018, it had 0 buys, and 1 insider sale for $11.54 million activity. 205,000 shares valued at $11.54 million were sold by GENTZKOW PAUL F on Friday, February 2.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: